COMMUNIQUÉS West-GlobeNewswire

Medtronic Delivers Significant Progress on Global Corporate Citizenship Efforts

08/11/2018 - 18:00

2018 Integrated Performance Report Shows Improvement on Environmental Stewardship and Diversity Aspirational Goals DUBLIN - November 8, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, is [...]

Hyperhidrosis Doesn’t Treat Itself

08/11/2018 - 17:44

Raising Awareness Among Healthcare Providers Because, When a Clinician Understands Excessive Sweating, It Makes All the Difference CENTER VALLEY, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Great hyperhidrosis care requires [...]

Report from Extraordinary General Meeting of Immunicum AB (publ) on 8 November 2018

08/11/2018 - 16:31

Press Release 8 November 2018 Report from Extraordinary General Meeting of Immunicum AB (publ) on 8 November 2018 The Extraordinary General Meeting (the "EGM") of Immunicum AB (publ), reg. no 556629-1786, was held today [...]

Medtronic Begins Renal Denervation Study for High Blood Pressure Patients Prescribed Anti-Hypertensive Medication

08/11/2018 - 15:31

FDA-Approved Study Furthers Medtronic Commitment to Generate Meaningful Clinical Evidence for Use of Renal Denervation to Treat Uncontrolled Hypertension DUBLIN - November 8, 2018 - Medtronic plc (NYSE:MDT) today [...]

BioSyent Schedules Q3 2018 Earnings Release for November 21, 2018

08/11/2018 - 15:22

TORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2018 on Wednesday, November [...]

OPKO Health to Announce Third Quarter 2018 Financial Results on November 9, 2018

08/11/2018 - 15:12

MIAMI, Nov. 08, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to announce its operating and financial results for the three and nine months ended September 30, 2018 after the close of the U.S. financial [...]

OncBioMune Phase 2 Clinical Trial to Begin Enrollment; Company Announces Other Developments and Corporate Milestones

08/11/2018 - 15:08

BATON ROUGE, La., Nov. 08, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Sienna Biopharmaceuticals® Reports Third Quarter 2018 Financial Results

08/11/2018 - 15:05

WESTLAKE VILLAGE, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage medical dermatology and aesthetics company, today reported the Company’s financial results for [...]

RAMSAY GENERALE DE SANTE : Final outcome OPA Capio

08/11/2018 - 15:01

PRESS RELEASE THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, OR SOUTH AFRICA. THE OFFER HAS NOT BEEN MADE TO (AND ACCEPTANCES [...]

RAMSAY GENERALE DE SANTE contrôle 98,51% du capital de Capio à l'issue de la période d'acceptation prolongée

08/11/2018 - 15:01

COMMUNIQUE DE PRESSE LE PRESENT COMMUNIQUE DE PRESSE NE PEUT ETRE, DIRECTEMENT OU INDIRECTEMENT, DISTRIBUE OU PUBLIE EN AUSTRALIE, CANADA, HONG KONG, JAPON, NOUVELLE ZELANDE, OU AFRIQUE DU SUD. L'OFFRE N'A PAS ETE FAITE [...]

Nemaura Medical Inc. Reports Second Quarter 2018 Financial Results

08/11/2018 - 15:00

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by people with diabetes [...]

Cabaletta Bio Emerges Out of University of Pennsylvania to Develop CAAR T Cell Technology to Treat B Cell-mediated Autoimmune Diseases

08/11/2018 - 15:00

-- Signs exclusive license agreement and multi-year sponsored research agreements with University of Pennsylvania -- C ompletes $38 million Series A financing to advance lead asset, DSG3-CAART for mucosal pemphigus [...]

CohBar Co-Founder and Scientific Advisor Dr. David Sinclair Named as one of TIME Magazine’s Health Care 50

08/11/2018 - 15:00

Cited for his groundbreaking work on the underlying metabolic causes of aging MENLO PARK, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing [...]

Wave Life Sciences to Present at the Jefferies 2018 London Healthcare Conference

08/11/2018 - 14:59

CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases [...]

Genmab to Present at the Jefferies 2018 London Healthcare Conference

08/11/2018 - 14:57

Media Release Copenhagen, Denmark; November 8, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that the company’s CEO, Jan van de Winkel, Ph.D., will present an update at the Jefferies 2018 London Healthcare [...]

Novelion Therapeutics Subsidiary Enters Into Term Loan Agreement and Novelion Provides Business Update

08/11/2018 - 14:48

- New Aegerion loan facility, provided by existing bondholders, strengthens balance sheet and is expected to provide bridge to a potential comprehensive long-term capital restructuring - Company expects to achieve [...]

SELLAS Life Sciences to Provide Third Quarter 2018 Financial Results and Corporate Update on November 15, 2018

08/11/2018 - 14:45

NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]

Homology Medicines to Present at Stifel Healthcare Conference

08/11/2018 - 14:30

BEDFORD, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Company management will present during a fireside chat at the Stifel [...]

Albireo to Present at Investor Conferences in November

08/11/2018 - 14:30

BOSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]